SK Biopharm IPO Industry Analysis & Contract Details
In this insight, we provide further details on the SK Biopharmaceuticals (BIO SK) IPO, including the industry and competitive analysis. We have...
227 Views
Biolidics, iX Biopharma & Hyphens Pharma Outpace Peers in 2020 YTD
Singapore’s most traded primary-listed stocks that represent medical equipment manufacturing, biotech and pharmaceuticals all generated gains...
73 Views
U.S. Equities: Upside Momentum Lost, But Not Breaking Down
In today's report we highlight key levels and several metrics we are watching that will provide us clues as to where the S&P 500 is headed...
434 Views
Personalis IPO: Personalising Cancer Trials and Treatments; Upside from Growth in Cancer Market
Personalis offers genomic sequencing to bio-pharmaceutical companies by fully analyzing sample tissue data of cancer patients. It provides its...
579 Views
Amarin--Our Talks With The CEO & An Update on New Trial Data Released at ACC Conference
Strong Q1 to Come: We recently had a call with Amarin's CEO, John Thero, and update our model with quarterly estimates. Q1 should see revenue...
2.6k Views